格隆汇3月5日丨康臣药业(01681.HK)此宣布,公司将于2025年3月26日(星期三)举行董事局会议,以处理以下事项:1.审阅及批准集团截至2024年12月31日止年度经审核综合财务报表("年度业绩");2.审阅及批准将根据香港联合交易所有限公司证券上市规则公布的集团年度业绩公告草案;3.考虑派发末期股息(如有);4.考虑召开公司应届股东周年大会的相关事宜;及5.考虑及批准其他事项(如有)。【...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.